:: Library Catalog

Imagen de Portada

Guardado en:

Detalles Bibliográficos
Autores principales:	Lauren M. Quinn, Olga Boiko, Josephine Elliott, Matthew Randell, Ian Litchfield, Felicity Boardman, Renuka P. Dias, Sheila M. Greenfield, Parth Narendran
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Diabetes, Obesity and Metabolism
Acceso en línea:	https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.16639
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Advancing Early‐Stage Type 1 Diabetes Care: Future Focused Pathways for Identification, Screening, Diagnosis, and Monitoring
por: Chantal Mathieu, et al.
Publicado: (2026)

Efficacy and safety of once‐weekly insulin icodec in type 2 diabetes: A meta‐analysis of ONWARDS phase 3 randomized controlled trials
por: Sahana Shetty, et al.
Publicado: (2024)

Treatment effect of semaglutide 2.4 mg on health‐related quality of life from STEP 1 SF‐6D derived from SF ‐36 with Australian weights
por: Pavol Kral, et al.
Publicado: (2024)

Clinical characteristics and outcomes of diabetes‐related ketoacidosis ( DKA ) in sodium‐glucose co‐transporter‐2 inhibitor ( SGLT2i ) users with type 2 diabetes
por: Angelica Sharma, et al.
Publicado: (2025)

Interactive online calculator for estimation of muscle and hepatic insulin sensitivity in adults with Type 1 diabetes using clinical and research biomarkers
por: Andrzej S. Januszewski, et al.
Publicado: (2026)

Prevalence of MASLD in children and adolescents with type 1 diabetes: A meta‐analysis
por: Felipe S. Moura, et al.
Publicado: (2024)

Sex as a modifier of genetic risk for type 1 diabetes
por: Hui‐Qi Qu, et al.
Publicado: (2025)

Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
por: Irl B. Hirsch, et al.
Publicado: (2024)

Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model
por: Marga A. G. Helmink, et al.
Publicado: (2024)

Effect of semaglutide add‐on therapy for people living with type 1 diabetes and excess weight
por: Noga C. Minsky, et al.
Publicado: (2025)

Omnipod 5 in children and adolescents with type 1 diabetes: Improved outcomes with fewer boluses
por: Davide Tinti, et al.
Publicado: (2025)

A Four‐Variant T1D Genetic Risk Score to Classify Type 1 and Monogenic Diabetes in Chinese Patients
por: Wei Liu, et al.
Publicado: (2026)

Cost‐Effectiveness of Automated Insulin Delivery Systems in Paediatrics, T1D and T2D Adults Across Four Nordic Countries
por: Johan Jendle, et al.
Publicado: (2026)

Pre‐dinner walks may be superior to post‐dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed‐loop insulin delivery systems
por: Lauren V. Turner, et al.
Publicado: (2024)

Sleep duration and association with cardiometabolic health in adolescents and adults with type 1 diabetes: Results from the BCQR‐T1D study
por: Stacey L. Simon, et al.
Publicado: (2024)

Geographic variation in sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia
por: Juliana de Oliveira Costa, et al.
Publicado: (2024)

Effectiveness of add‐on therapy with SGLT2 inhibitors or GLP ‐1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study
por: Christina Baechle, et al.
Publicado: (2024)

Incretin‐based therapies for individuals with obesity and heart failure with mildly reduced or preserved ejection fraction: A systematic review and meta‐analysis of randomized controlled trials
por: Thomaz Alexandre Costa, et al.
Publicado: (2025)

No evidence from euglycaemic–hyperinsulinaemic clamp studies for greater insulin sensitivity in adults with type 1 diabetes using insulin pump versus multiple daily insulin injections—Post hoc meta‐analysis
por: Andrzej S. Januszewski, et al.
Publicado: (2025)

Human adipose tissue expression of uncoupling protein 1 in response to intravenous administration of B‐type natriuretic peptide hormone: Results from a randomized controlled crossover study
por: Katherine N. Bachmann, et al.
Publicado: (2024)

Characterizing body composition modifying effects of a glucagon‐like peptide 1 receptor‐based agonist: A meta‐analysis
por: Ruoyang Jiao, et al.
Publicado: (2024)

An overview of randomized clinical trials of fixed‐ratio combinations of basal insulin plus GLP ‐ 1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes
por: Geremia B. Bolli, et al.
Publicado: (2025)

Role of the liver in the sustained normalisation of A1c over 2 years following short‐term insulin therapy in early type 2 diabetes
por: Andrew Wu, et al.
Publicado: (2024)

Safety and efficacy of hybrid closed‐loop insulin pump therapy in adolescents and adults with type 1 diabetes in China
por: Jing Shen, et al.
Publicado: (2025)

Glycaemic control metrics and metabolic dysfunction–associated steatotic liver disease in children and adolescents with type 1 diabetes
por: Claudio Maffeis, et al.
Publicado: (2024)

Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
por: Yongwen Zhou, et al.
Publicado: (2025)

Practical limitations of complex insulin therapies in type 2 diabetes: Focus on therapy simplification using fixed‐ratio combinations of basal insulin and a glucagon‐like peptide‐1 receptor agonist
por: Luděk Horváth, et al.
Publicado: (2025)

One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA
por: Mengqing Zhang, et al.
Publicado: (2024)

An MRI study of pancreatic atrophy in children with type 1 diabetes: Heterogeneity, disease duration effects, and progression prediction models
por: Zheng Cai, et al.
Publicado: (2025)

GLP ‐1–based therapies, the stepwise trap, and missed surgical windows: A policy perspective on delayed access to bariatric surgery
por: Kuo‐Feng Hsu
Publicado: (2025)

Efficacy and safety of once‐weekly basal insulin therapy in people with type 1 diabetes: A systematic review and meta‐analysis
por: Ludovico Di Gioia, et al.
Publicado: (2025)

Follow‐up and monitoring programme in children identified in early‐stage type 1 diabetes during screening in the general population of Italy
por: Valentino Cherubini, et al.
Publicado: (2024)

Social disadvantage and technology use among adults with type 1 diabetes in Quebec: A cross‐sectional study using data from the Canadian T1D ( BETTER ) Registry
por: Parisa Khodabandehloo, et al.
Publicado: (2025)

Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP ‐ 1RA ‐based weight‐loss therapies
por: Reimar W. Thomsen, et al.
Publicado: (2025)

Sick days glycaemic outcomes in a cohort of children and adolescents with type 1 diabetes using an AID system—A preliminary report
por: Davide Tinti, et al.
Publicado: (2025)

Time in tight range in automated insulin delivery system users: Real‐world data from children and adolescents with type 1 diabetes
por: Claudia Piona, et al.
Publicado: (2024)

Validation of anthropometric and bioelectrical impedance equations for the prediction of fat mass amongst South African children
por: M. T. Hudda, et al.
Publicado: (2025)

The interaction of vitamin D supplementation with Omentin‐1 gene polymorphism on metabolic biomarkers, omentin‐1 levels and anthropometric measures in women with prediabetes: A double‐blind randomized controlled trial
por: Roghayeh Molani‐Gol, et al.
Publicado: (2025)

Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials
por: Paschalis Karakasis, et al.
Publicado: (2024)

If treating obesity with GLP ‐1‐based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials
por: Anastasios Tentolouris, et al.
Publicado: (2026)